Daljit Singh Aurora

CIK: 0001793971

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)14 (20.3%)

Position reduction

Option Exercises (M)16 (23.2%)

Derivative conversions

Awards (A)18 (26.1%)

Compensation grants

Other (G, F, J, C, D, …)21 (30.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

NMRA

Neumora Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (69 total)

NMRA
Neumora Therapeutics, Inc.
Aug 21, 2026
Exercise(M)
Direct
20.6K shares at avg. $0.72$15K
NMRA
Neumora Therapeutics, Inc.
Aug 21, 2026
Sale(S)
Indirect
21.1K shares at avg. $1.60$34K
NMRA
Neumora Therapeutics, Inc.
Aug 21, 2026
Exercise(M)
Indirect
21.1K shares at avg. $0.72$15K
NMRA
Neumora Therapeutics, Inc.
Aug 21, 2026
Sale(S)
Direct
20.6K shares at avg. $1.59$33K
NMRA
Neumora Therapeutics, Inc.
Aug 20, 2026
Exercise(M)
Indirect
21.7K shares at avg. $0.72$16K
NMRA
Neumora Therapeutics, Inc.
Aug 20, 2026
Exercise(M)
Direct
67.7K shares at avg. $0.72$49K
NMRA
Neumora Therapeutics, Inc.
Aug 20, 2026
Exercise(M)
Indirect
45K shares at avg. $0.72$32K
NMRA
Neumora Therapeutics, Inc.
Aug 20, 2026
Sale(S)
Direct
67.7K shares at avg. $1.51$103K
NMRA
Neumora Therapeutics, Inc.
Aug 20, 2026
Sale(S)
Indirect
66.7K shares at avg. $1.51$101K
NMRA
Neumora Therapeutics, Inc.
Aug 20, 2026
Award(A)
Stock Option (Right to Buy)
Direct
200K shares-
NMRA
Neumora Therapeutics, Inc.
Aug 19, 2026
Sale(S)
Indirect
30.9K shares at avg. $1.65$51K
NMRA
Neumora Therapeutics, Inc.
Aug 19, 2026
Exercise(M)
Indirect
30.9K shares at avg. $0.72$22K
NMRA
Neumora Therapeutics, Inc.
Aug 19, 2026
Sale(S)
Direct
31K shares at avg. $1.65$51K
NMRA
Neumora Therapeutics, Inc.
Aug 19, 2026
Exercise(M)
Direct
17.7K shares at avg. $0.72$13K
NMRA
Neumora Therapeutics, Inc.
Aug 19, 2026
Exercise(M)
Direct
13.3K shares at avg. $0.72$10K
NMRA
Neumora Therapeutics, Inc.
Aug 18, 2026
Exercise(M)
Indirect
35K shares at avg. $0.72$25K
NMRA
Neumora Therapeutics, Inc.
Aug 18, 2026
Sale(S)
Direct
34.2K shares at avg. $1.58$54K
NMRA
Neumora Therapeutics, Inc.
Aug 18, 2026
Exercise(M)
Direct
34.2K shares at avg. $0.72$25K
NMRA
Neumora Therapeutics, Inc.
Aug 18, 2026
Sale(S)
Indirect
35K shares at avg. $1.59$55K
NMRA
Neumora Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Direct
1 shares at avg. $0.72$0.72
NMRA
Neumora Therapeutics, Inc.
Aug 17, 2026
Sale(S)
Indirect
55K shares at avg. $1.50$83K
NMRA
Neumora Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Direct
1.4K shares at avg. $0.72$1K
NMRA
Neumora Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Indirect
29.7K shares at avg. $0.72$21K
NMRA
Neumora Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Indirect
25.3K shares at avg. $0.72$18K
NMRA
Neumora Therapeutics, Inc.
Aug 17, 2026
Exercise(M)
Direct
15.4K shares at avg. $0.72$11K

		Type	Shares	Price		Ownership
Aug 21, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	20,553	$0.72	$14,798	Direct
Aug 21, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	21,055	$1.60	$33,600	Indirect
Aug 21, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	21,055	$0.72	$15,160	Indirect
Aug 21, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	20,553	$1.59	$32,780	Direct
Aug 20, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	21,685	$0.72	$15,613	Indirect
Aug 20, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	67,741	$0.72	$48,774	Direct
Aug 20, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	45,026	$0.72	$32,419	Indirect
Aug 20, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	67,741	$1.51	$102,587	Direct
Aug 20, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	66,711	$1.51	$101,000	Indirect
Aug 20, 2026	NMRA Neumora Therapeutics, Inc.	Award(A) Stock Option (Right to Buy)	200,000	-	-	Direct
Aug 19, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	30,918	$1.65	$50,888	Indirect
Aug 19, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	30,918	$0.72	$22,261	Indirect
Aug 19, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	31,000	$1.65	$51,029	Direct
Aug 19, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	17,732	$0.72	$12,767	Direct
Aug 19, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	13,268	$0.72	$9,553	Direct
Aug 18, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	34,987	$0.72	$25,191	Indirect
Aug 18, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	34,162	$1.58	$54,137	Direct
Aug 18, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	34,162	$0.72	$24,597	Direct
Aug 18, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	34,987	$1.59	$55,486	Indirect
Aug 17, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	1	$0.72	$1	Direct
Aug 17, 2026	NMRA Neumora Therapeutics, Inc.	Sale(S)	55,016	$1.50	$82,783	Indirect
Aug 17, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	1,424	$0.72	$1,025	Direct
Aug 17, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	29,737	$0.72	$21,411	Indirect
Aug 17, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	25,279	$0.72	$18,201	Indirect
Aug 17, 2026	NMRA Neumora Therapeutics, Inc.	Exercise(M)	15,355	$0.72	$11,056	Direct

1-25 of 69 transactions

About Aurora Daljit Singh

Aurora Daljit Singh (SEC CIK 0001793971) files insider reports with the SEC as Officer of Neumora Therapeutics, Inc. (NMRA).

Signal8 holds 9 ownership filings by Aurora Daljit Singh, all Form 4s, filed between Sep 13, 2024 and Aug 21, 2026. Those filings report 69 transactions, the latest on Aug 21, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Aurora Daljit Singh's filings is in WATERTOWN, MA.

Recent filings by Aurora Daljit Singh

Aug 21, 2026: Option exercise of NMRA shares (Form 4, code M).
Aug 21, 2026: Open-market sale of NMRA shares (Form 4, code S).
Aug 21, 2026: Option exercise of NMRA shares (Form 4, code M).
Aug 21, 2026: Open-market sale of NMRA shares (Form 4, code S).
Aug 20, 2026: Option exercises of NMRA shares (3 lines, Form 4, code M).

Other insiders filing for Neumora Therapeutics, Inc. (NMRA)

How to read Form 4 transaction codes